Vial Alternatives & Competitors
12 companies similar to Vial — Vial is a next-gen pharma company advancing best-in-class biologics and RNA ther...
Companies similar to Vial
RIGImmune Inc.
Targeted non-LNP Delivery of RNA Therapeutics
ADARx Pharmaceuticals Inc.
Our vision is to provide effective and safe RNA therapeutics to patients who suffer from i...
Pannex Therapeutics Inc.
We are the Pannexin people.
Click Therapeutics, Inc.
Develops and commercializes software as prescription medical treatments for people with un...
Rival Readout
Competing with Vial? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
PharmEnable Therapeutics
Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innova...
Odyssey Therapeutics
Building a machine learning-based platform to develop novel therapeutics focusing on cance...
KSQ Therapeutics, Inc.
The company is deploying CRISPRomics for novel drug development across broad therapeutic a...
Alchemab Therapeutics Ltd
Pioneering Patient-led Antibody Therapeutics
Onchilles Pharma
Developing drug candidates that have the potential to be broadly effective against a wide...
About Vial
Vial, founded in 2020, is carving a niche in the biotechnology and pharmaceutical industries with its commitment to developing next-generation biologics and RNA therapeutics. Headquartered in the United States, this innovative pharma company is targeting numerous areas of unmet medical need, setting it apart from its p...
Target Discovery, Molecule Design, RNA, Antibody, and Small Molecule Program Development, Experimental Validation, Automated Clinical Trials
Biopharmaceutical Companies, Healthcare Providers, Investors in Biotechnology, Scientific Researchers, Patients with Immune and Inflammatory Disorders
Biologics, RNA Therapeutics, Pharmacological Innovation, Clinical Trials, Computational Drug Design, Dermatology Research, Ophthalmology Research, Oncology Research, Gastroenterology Research, Cardiology Research, Neurology Research, Contract Research Organization (CRO), Biotech Scalability
B2B, D2C, B2D
Service Fee, Licensing, Consulting Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Vial: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Vial on 2 Jul 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.